Ali Mojtahedi

Prof. Ali Mojtahedi


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2022 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
MMMajid Taati Moghadam
Majid Taati Moghadam
NANour Amirmozafari
Nour Amirmozafari
AMAli Mojtahedi
Ali Mojtahedi
BBBabak Bakhshayesh
Babak Bakhshayesh
ASAref Shariati
Aref Shariati
FJFaramarz Masjedian Jazi
Faramarz Masjedian Jazi
Objective: This case‐control study was designed to compare the composition of the predominant oral bacterial microbiome in Alzheimer's disease (AD) and control group.Subject: A total of 30 adult participants (15 AD and 15 healthy individuals) were entered in this study. The composition of oral bacterial microbiome was examined by quantitative real‐time polymerase chain reaction (qPCR) using bacterial 16S rDNA gene. The levels of systemic inflammatory cytokines in both groups were assessed using enzyme‐linked immunosorbent assays (ELISA).Results: The loads of Porphyromonas gingivalis, Fusobacterium nucleatum, and Prevotella intermedia were significantly more abundant in the AD compared to the control group (p < 0.05). Although Aggregatibacter actinomycetemcomitans and Streptococcus mutans were relatively frequent in the AD group, no significance difference was observed in their copy number between two groups. Although the concentrations of IL‐1, IL‐6, and TNF‐α were higher in the AD group, there was a significant difference in their levels between the two groups (p < 0.05). Finally, there was a significant relationship between increased number of pathogenic bacteria in oral microbiome and higher concentration of cytokines in patient's blood.Conclusion: Our knowledge of oral microbiome and its exact association with AD is rather limited; our study showed a significant association between changes in oral microbiome bacteria, increased inflammatory cytokines, and AD.

1 December 2016 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Closed access
MHMaryam Haghighatpanah
Maryam Haghighatpanah
Amir Sasan Mozaffari NejadAmir Sasan Mozaffari Nejad
Amir Sasan Mozaffari Nejad
AMAli Mojtahedi
Ali Mojtahedi
NANour Amirmozafari
Nour Amirmozafari
HZHabib Zeighami
Habib Zeighami

1 September 2019 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
MHMaryam Haghighatpanah
Maryam Haghighatpanah
AMAli Mojtahedi
Ali Mojtahedi
Background: Urinary tract infections (UTIs) are one of the most frequent human infectious diseases causing considerable amount of morbidity and mortality. The present study aimed to investigate the occurrence of antibiotics resistance and virulence genes among Escherichia coli strains isolated from UTIs in the north of Iran. Methods: This cross-sectional study was performed at 5 teaching hospitals in Rasht in the north of Iran. Totally, 129 E. coli isolates were identified by standard microbiologic tests. Antimicrobial susceptibility pattern was determined using disk diffusion method. The presence of virulence genes was detected by PCR method. Results: The results of antibiotic susceptibility showed that the highest resistance rates were to ampicillin (78.3%) followed by nalidixic acid (74.4%) and trimethoprim/sulfamethoxazole (69.8%). On the other hand, the highest susceptibility was toward nitrofurantoin (96.1%) and imipenem (92.2%). Further analysis revealed that the rate of ESBL-producing and multiple-drug resistant isolates was 51.2% and 84.5%, respectively. Molecular analysis revealed that traaT (87.6%) gene was the most prevalent virulence factors followed by fyuA (86%) and kpsmt (76%) genes. Also, fimH gene was the most frequently detected adhesion-associated gene with 74.4%. Conclusion: In summary, our results showed a remarkable rate of drug resistance and heterogeneity for virulence factors among E. coli strains isolated from UTIs in the north of Iran. The emergence of such strains can be a predictive marker for their persistence in the hospital and consequently a significant threat for hospitalized patients.

20 November 2021 in New Microbes and New Infections
Verified
Journal Article
Open access
MSM. Sadeghi
M. Sadeghi
HEH. Sedigh Ebrahim-Saraie
H. Sedigh Ebrahim-Saraie
AMAli Mojtahedi
Ali Mojtahedi
Beta-lactam resistance in Gram-negative bacteria, especially Escherichia coli, is a main clinical problem. It is often caused by the production of β-lactamases, particularly extended-spectrum β-lactamases (ESBLs) or AmpC enzymes. This study was undertaken to characterize ESBL and AmpC producers among Escherichia coli isolates from urine samples. During six months, 263 E. coli isolates were detected by standard biochemical tests. The isolates were screened for ESBL production by the double-disk synergy test using Ceftazidime (30 μg) and Cefotaxime (30 μg) disks and confirmed by combined disk diffusion test using Clavulanic acid. AmpC production was confirmed by an AmpC disk test based on filter paper disks impregnated with EDTA. The presence of genes encoding TEM, SHV, CTX-M, CIT, FOX, MOX, ACC, and EBC were detected by PCR. 263 E. coli isolates were selected for the combined disk (Ceftazidime, Cefotaxime, and Clavulanic acid) assay in the disk agar diffusion test. In the combined disk assay, among 263 isolates, 121 (46%) isolates were detected as ESBLs, and none of the isolates were AmpC producers. PCR performed on all ESBL producers and blaSHV, blaTEM, and blaCTX-M were detected in 42 (34.7%), 44 (36.4%), and 47 (38.8%) cases, respectively. Also, from 48 Isolates with zone diameters of less than or equal to 18 mm to Cefoxitin, 7 (14.6%), 4 (8.3%), and 9 (18.8%) cases contained MOX, EBC, and CIT genes, respectively. DHA, FOX, and ACC genes were not detected in any sample. Since pathogens evolve in the hospital setting, updating local data, such as this research, offers scientific evidence to improve the outcome of nosocomial infections.

25 November 2011 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
SNShadman Nemati
Shadman Nemati
AMAli Mojtahedi
Ali Mojtahedi
SNSeyyed Ebrahim Naghavi
Seyyed Ebrahim Naghavi
RBRahmatollah Banan
Rahmatollah Banan
FZFiroozeh Zia
Firoozeh Zia

1 June 2020 in Acta Microbiologica Et Immunologica Hungarica
Verified
Journal Article
Closed access
PDF file
MHMeysam Hasannejad-Bibalan
Meysam Hasannejad-Bibalan
AMAli Mojtahedi
Ali Mojtahedi
MEMorteza Eshaghi
Morteza Eshaghi
MRMahdi Rohani
Mahdi Rohani
MPMohammad Reza Pourshafie
Mohammad Reza Pourshafie
MTMalihe Talebi
Malihe Talebi
Inflammatory bowel disease (IBD) comprises two major illnesses: Crohn's disease (CD) and ulcerative colitis (UC). Dextran sulfate sodium (DSS) mouse colitis model has been used in understanding the mechanism of IBD. This study was conducted to examine selected Lactobacillus spp. as potential IBD treatment in the DSS-induced animal model. Balb/c mice were used and colitis was induced by adding 5% dextran sodium sulfate into the drinking water for 8 days. Colon length, disease activity index (DAI) and histological analysis were measured as markers of inflammation in DSS colitis mice. The majority of the Lactobacillus species significantly prevented the shortening of the colon length compared with the DSS group. The DAI scores of mice were significantly reduced following usage of four Lactobacillus strains included: Lactobacillus plantarum 03 and 06, Lactobacillus brevis 02 and Lactobacillus rhamnosus 01. The histological analysis exhibited that oral administration of Lactobacillus strains had therapeutic effects on mice colitis. L. plantarum and L. brevis showed better therapeutic effect against DSS-induced acute colitis mice. The probiotic activities of these three isolates indicated that the probiotic effects were strain specific and none of these useful bacteria could exhibit all of the valued probiotic properties simultaneously.